Plain-English translation of NCT07190339 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing pulsed radiofrequency (pRF) treatment, a minimally invasive procedure that uses gentle heat energy to calm the nerves around your hip joint. The procedure is guided by ultrasound — the same safe imaging technology used during pregnancy — so doctors can see exactly where they're working. This treatment is being studied as a way to reduce chronic hip pain in people with arthritis who haven't found relief with standard approaches like painkillers and physical therapy.
Many people with hip arthritis can't take strong medications or aren't ready for hip replacement surgery, but they still suffer from significant pain. This new treatment offers a middle path — a safer alternative to older radiofrequency techniques that carried risks of nerve damage. Researchers want to see whether this gentler approach can help people like you manage pain and stay active without major surgery.
You likely qualify if…
You likely don't qualify if…
You would receive one pulsed radiofrequency treatment procedure performed under ultrasound guidance at the hospital. The procedure targets the nerves around your hip joint to reduce pain. You would then return for follow-up appointments so the research team can monitor how well the treatment works and track your pain levels and ability to move over time.
AI-generated summary from trial data · Jul 3, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Diskapi Teaching and Research Hospital
Enrollment target
~40 participants
Started
September 2025
Primary completion
April 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Emine Yuksel, TR
Diskapi TRH
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.